Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1485 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Cellectis S.A.. (11/21/16). "Press Release: Cellectis to Participate in Oppenheimer Life Sciences Summit, NY and in Piper Jaffray 28th Annual Health Care Conference, NY". New York, NY. 2016-11-21
Novasep Holding S.A.S. (11/17/16). "Press Release: Novasep and Japanese Agent AR Brown Extend Partnership". Cambridge. 2016-11-17
Enterome Bioscience S.A.. (11/16/16). "Press Release: Bristol-Myers Squibb and Enterome SA Announce Immuno-oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules". New York, NY & Paris. 2016-11-16
Cellnovo. (11/16/16). "Press Release: Cellnovo Files for 510(k) Approval with the FDA for Its Mobile, Connected, All-in-one Diabetes Management System". Paris. 2016-11-16
Bruker Corporation. (11/16/16). "Press Release: Cetim Facility Receives Bruker Contour CMM Dimensional Analysis System". San José, CA & Senlis. 2016-11-16
Cellectis S.A.. (11/15/16). "Press Release: Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate – UCART123". New York, NY. 2016-11-15
Neovacs S.A.. (11/15/16). "Press Release: Neovacs Acquires Interferon alpha Manufacturing Technology from AmegaBiotech". Paris & Boston, MA. 2016-11-15
OSE Immunotherapeutics S.A.. (11/15/16). "Press Release: Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases". Geneva & Nantes. 2016-11-15
UroMems. (11/15/16). "Press Release: UroMems Closes €14m Financing to Develop Its Smart Artificial Urinary Sphincter to Market". Grenoble. 2016-11-15
Stallergenes Greer plc. (11/14/16). "Press Release: Collaboration with the Sean N. Parker Center at Stanford University". 2016-11-14
bioMérieux S.A.. (11/14/16). "Press Release: Business Review for the Nine Months Ended September 30, 2016". Marcy l’Étoile. 2016-11-14
bioMérieux S.A.. (11/10/16). "Press Release: bioMérieux Launches eMAG, a New Generation Automated System for the Extraction of DNA and RNA". Marcy l’Étoile. 2016-11-10
Valneva S.E.. (11/9/16). "Press Release: Valneva Reports Strong Business Performance in First Nine Months, Company Increases Financial Guidance for Full Year 2016". Lyon. 2016-11-09
TxCell S.A.. (11/8/16). "Press Release: TxCell – Financial information for the 3rd Quarter of 2016". Valbonne. 2016-11-08
bioMérieux S.A.. (11/7/16). "Press Release: Pierre Boulud Appointed Corporate Vice President of the Asia Pacific Region at bioMérieux". Marcy l’Étoile. 2016-11-07
Neovacs S.A.. (11/7/16). "Press Release: Neovacs Enrolls the First U.S. Patient in Phase IIb study of IFNa Kinoid for Treatment of Systemic Lupus Erythematosus (SLE)". Paris & Boston, MA. 2016-11-07
CorWave. (11/4/16). "Press Release: CorWave Raises $17.1 Million in Series B Financing". Paris. 2016-11-04
TxCell S.A.. (11/3/16). "Press Release: TxCell Announces the Issue of a Second Tranche of Convertible Notes of €2 Million as Planned as Part of the OCABSA Financing". Valbonne. 2016-11-03
Novasep Holding S.A.S. (11/3/16). "Press Release: Refinancing – Financial Information about Exchange Notes and Warrants". Lyon. 2016-11-03
Neovacs S.A.. (11/3/16). "Press Release: Neovacs to Attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016". Paris & Boston, MA. 2016-11-03
Sanofi S.A.. (10/28/16). "Press Release: Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis". Paris & Tarrytown, NY. 2016-10-28
Sanofi S.A.. (10/28/16). "Press Release: Sanofi Announces Strong Q3 2016 Results". Paris. 2016-10-28
PathoQuest S.A.S.. (10/27/16). "Press Release: PathoQuest Achieves CE Mark for the iDTECT Blood Test". 2016-10-27
Onxeo S.A.. (10/27/16). "Press Release: Onxeo Announces Promising Results from Preclinical Study of Beleodaq Combination with Checkpoint Inhibitors". Paris & Copenhagen. 2016-10-27
Erytech Pharma. (10/27/16). "Press Release: Erytech Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer". Lyon. 2016-10-27
Novasep Holding S.A.S. (10/26/16). "Press Release: Novasep Anounces the Success of Its Refinancing". Lyon. 2016-10-26
Onxeo S.A.. (10/25/16). "Press Release: Onxeo Reports Third Quarter 2016 Financial Information and Provides Business Update". Paris & Copenhagen. 2016-10-25
TxCell S.A.. (10/19/16). "Press Release: TxCell and University of British Columbia Start Collaboration to Develop CAR-Tregs in Solid Organ Transplantation". Valbonne. 2016-10-19
bioMérieux S.A.. (10/17/16). "Press Release: Lyme Disease Diagnostic Tests". Marcy l’Étoile. 2016-10-17
IntegraGen S.A.. (10/14/16). "Press Release: IntegraGen Reports Revenues for First Half of 2016". Évry. 2016-10-14
TxCell S.A.. (10/13/16). "Press Release: TxCell Appoints Dr. Li Zhou as Vice President Cell Engineering to Lead Its CAR-Treg Programs". Valbonne. 2016-10-13
Neovacs S.A.. (10/12/16). "Press Release: Neovacs Signs a Cooperation Agreement with the Department of Diabetes at the Reputed Hospital Cochin in Paris". Paris. 2016-10-12
Scienion AG. (10/12/16). "Press Release: Scienion Opens French Subsidiary Cellenion with Focus on Controlled Cell Dispensing Technologies". Berlin & Lyon. 2016-10-12
Transgene S.A.. (10/11/16). "Press Release: Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study". Strasbourg. 2016-10-11
IntegraGen S.A.. (10/10/16). "Press Release: New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress". Copenhagen. 2016-10-10
bioMérieux S.A.. (10/10/16). "Press Release: BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi Join Forces against Sepsis". 2016-10-10
Onxeo S.A.. (10/10/16). "Press Release: Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco". Paris & Copenhagen. 2016-10-10
Genfit S.A.. (10/6/16). "Press Release: Genfit Successfully Raises EUR 33.9 Million in Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-06
Advanced Accelerator Applications S.A.. (10/5/16). "Press Release: Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares". New York, NY. 2016-10-05
Mayoly Spindler. (10/5/16). "Press Release: Mayoly Spindler Acquires the Swedish Laboratory Kibion". Paris. 2016-10-05
PX’Therapeutics S.A.. (10/5/16). "Press Release: PX’Therapeutics and Relief Therapeutics Holding AG Announce a Strategic Collaboration Agreement for the Recombinant Production of Atexakin Alfa". Grenoble & Geneva. 2016-10-05
Genfit S.A.. (10/5/16). "Press Release: Genfit Launches a Share Capital Increase through Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-05
Cellectis S.A.. (10/4/16). "Press Release: Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued in December 2014". New York, NY. 2016-10-04
Genfit S.A.. (10/3/16). "Press Release: New Scientific Data to be Presented During Next AASLD Annual Meeting, Strong Involvement in the First-Ever NASH-TAG Conference". Lille & Cambridge, MA. 2016-10-03
Sanofi S.A.. (9/30/16). "Press Release: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare". Paris. 2016-09-30
Onxeo S.A.. (9/30/16). "Press Release: Onxeo Raises €12.5 Million through Capital Increase with US and European Investors [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-30
Neovacs S.A.. (9/30/16). "Press Release: Half-year Results 2016 and Update on Operational Development". Paris. 2016-09-30
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
Onxeo S.A.. (9/29/16). "Press Release: Onxeo Launches Capital Increase [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-29
Oncodesign S.A.. (9/28/16). "Press Release: GSK and Oncodesign Announce Agreement for Oncodesign’s Acquisition of GSK’s Research Centre in France". 2016-09-28
Noxxon Pharma N.V.. (9/28/16). "Press Release: Noxxon Pharma NV Lists Its Shares on Alternext Paris [Not for United States, Australia, Canada or Japan or any other jurisdiction where unlawful]". Berlin. 2016-09-28
Genfit S.A.. (9/27/16). "Press Release: Genfit Is Filing for IND Submission for New Indication of Elafibranor in Primary Biliary Cholangitis (PBC)". Lille & Cambridge, MA. 2016-09-27
Erytech Pharma. (9/26/16). "Press Release: Erytech Completes Patient Enrollment in Phase 2 Trial of Eryaspase (Graspa) for Pancreatic Cancer". Lyon. 2016-09-26
Sanofi S.A.. (9/26/16). "Press Release: Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA". Paris & Tarrytown, NY. 2016-09-26
Genfit S.A.. (9/26/16). "Press Release: H1 2016 Results. Cash Position at End of Period at €94m and Significatn Advances in Elafibranor Program". Lille & Cambridge, MA. 2016-09-26
Novasep Holding S.A.S. (9/26/16). "Press Release: Refinancing – Launch of an Exchange Offer and Consent Solicitation [This press release may not be published, forwarded or distributed, directly or indirectly, in the United States, Canada, Australia or Ja 2016-09-26
Global Bioenergies S.A.. (9/23/16). "Press Release: Establishment of Flexible Bond Financing by the Reserved Issue of OCABSAs for an €11.25 Million Bond Loan on Condition of Shareholder Approval". Évry & Dubai. 2016-09-23
Global Bioenergies S.A.. (9/22/16). "Press Release: Publication of the Half-year Results to 30/06/2016. Net Loss for the Group of €6.7 Million in the First Half of 2016 – €9.1 Million in Cash at 30 June 2016". Évry. 2016-09-22
Genticel S.A.. (9/22/16). "Press Release: Genticel Presents First Half 2016 Financial Results and Updates Its Operational Outlook". Paris & Toulouse. 2016-09-22
Polyplus-transfection S.A.. (9/19/16). "Press Release: ArchiMed Acquires Biotech Specialist Polyplus-transfection". 2016-09-19
Enterome Bioscience S.A.. (9/19/16). "Press Release: Enterome Appoints Christophe Bonny as Chief Scientific Officer". Paris & Cambridge, MA. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Sanofi Files Suit in U.S. to Defend Patent Rights on Lantus and Lantus Solostar". Paris. 2016-09-16
Novasep S.A.. (9/14/16). "Press Release: Novasep and Triclinic Labs Enter a Strategic Alliance for Solid-state Chemistry Services". Lyon. 2016-09-14
Sanofi S.A.. (9/13/16). "Press Release: Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone". Paris. 2016-09-13
Onxeo S.A.. (9/12/16). "Press Release: Onxeo Announces First Outcomes of Livatag Preclinical Plan". Paris & Copenhagen. 2016-09-12
Cellectis S.A.. (9/8/16). "Press Release: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results". New York, NY. 2016-09-08
Innate Pharma S.A.. (9/8/16). "Press Release: First Half of 2016 – Building Momentum through Clinical Development and New Partnerships". 2016-09-08
Onxeo S.A.. (9/7/16). "Press Release: Combination of AsiDNA and PARP Inhibitors Demonstrates Synergistic Effect, Bypasses Genetic Restriction". Paris & Copenhagen. 2016-09-07
Onxeo S.A.. (9/7/16). "Press Release: Onxeo to Present at the 18th Annual Rodman and Renshaw Global Investment Conference in New York". Paris & Copenhagen. 2016-09-07
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Successfully Prices EUR 3 Billion Bond Issue". Paris. 2016-09-06
Novasep S.A.. (9/6/16). "Press Release: Novasep Appoints Dr. François D’Hooge as Bioconjugation Unit Manager". Lyon. 2016-09-06
Sanofi S.A.. (9/6/16). "Press Release: Sanofi Board of Directors Provides Update". Paris. 2016-09-06
TxCell S.A.. (9/5/16). "Press Release: TxCell to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016". Valbonne. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Appoints Allene M. Diaz to Its Board of Directors". Lyon. 2016-09-05
Erytech Pharma. (9/5/16). "Press Release: Erytech Reports Business and Financial Update for the First Half of 2016". Lyon. 2016-09-05
Servier. (9/1/16). "Press Release: Amgen and Servier Extend Omecamtiv Mecarbil Collaboration in Chronic Heart Failure". Thousand Oaks, CA & Suresnes. 2016-09-01
4P-Pharma. (9/1/16). "Press Release: Signature of a License Agreement with 4P-Pharma for the Development of an Anti-cancer Drug". Talence. 2016-09-01
Novasep S.A.. (9/1/16). "Press Release: Demonstration Project Started for the Conversion of Woody Biomass to Chemicals". Brussels. 2016-09-01
bioMérieux S.A.. (8/31/16). "Press Release: bioMérieux – First-Half 2016 Results". Marcy l’Étoile. 2016-08-31
Cerenis Therapeutics S.A.. (8/30/16). "Press Release: Completion of Patient Enrolment in the CARAT Study – Meeting the Clinical Schedule". Toulouse & Ann Arbor, MI. 2016-08-30
Neovacs S.A.. (8/30/16). "Press Release: Neovacs to Present at Two Major Investor Conferences. The 18th Annual Rodman & Renshaw Global Investment Conference & Bio Europe 2016". Paris & Boston, MA. 2016-08-30
TxCell S.A.. (8/24/16). "Press Release: TxCell Appoints Biogen’s Dr. Olivier Danos, Pioneer in Gene Therapy for Neurological Disorders, to Its Scientific Advisory Board". Valbonne. 2016-08-24
Theraclion S.A.. (8/18/16). "Press Release: Strong Interest of Investors in Theraclion – Capital increase Completed @ 100%. Total Amount Raised of €9,7M [Not for UK] 1,7 new shares issued at €5.98 per share". Malakoff. 2016-08-18
TxCell S.A.. (8/3/16). "Press Release: TxCell Announces the Effective Implementation of the Convertible Notes with Warrants (OCABSA) Financing and the Issue of a First Tranche for an Amount of €3 Million in Nominal Value [Not for US, CA, AU, JP]". Valbon 2016-08-03
Sanofi S.A.. (7/29/16). "Press Release: Sanofi Announces Q2 2016 Results". 2016-07-29
Biophytis S.A.. (7/29/16). "Press Release: Biophytis Receives Approval of bpifrance for an Innovation Loan of €1.1M to Finance the SARA-PK Trial". Romainville. 2016-07-29
Onxeo S.A.. (7/28/16). "Press Release: Onxeo Reports First-Half 2016 Business Update and Consolidated Financials". Paris & Copenhagen. 2016-07-28
Nicox S.A.. (7/28/16). "Press Release: Nicox Raises €18 Million to Finance Development of Its Pipeline [Not for distribution in or into the United States of America, Canada, Japan or Australia, except as permitted by applicable law ]". Philadeliphia, PA 2016-07-28
Sanofi S.A.. (7/28/16). "Press Release: Sanofi Receives FDA Approval of Adlyxin for Treatment of Adults with Type 2 Diabetes". Paris. 2016-07-28
Onxeo S.A.. (7/27/16). "Press Release: Onxeo Signs Exclusive License Agreement with Pint Pharma for the Commercialization of Beleodaq in PTCL in South America". Paris & Copenhagen. 2016-07-27
TxCell S.A.. (7/27/16). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2016". Valbonne. 2016-07-27
Novacyt S.A.. (7/20/16). "Press Release: Novacyt Half Year 2016 Revenues. Continued Strong Growth in Novaprep Sales – Strong Growth from the Acquisition of Primerdesign". Paris & Cambridge. 2016-07-20
Genomic Vision S.A.. (7/20/16). "Press Release: Genomic Vision Is Accelerating Its Clinical Trial in Cervical Cancer with an Additional Study in the Czech Republic". Bagneux. 2016-07-20
Neovacs S.A.. (7/19/16). "Press Release: EUR 8 Million Capital Increase Successfully Completed [Not for distribution, directly or indirectly in the United States, Canada, Australia and Japan] ". Paris, Boston, MA & Port Heueneme, CA. 2016-07-19
Neovacs S.A.. (7/19/16). "Press Release: Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids". Paris, Boston, MA & Port Heueneme, CA. 2016-07-19
bioMérieux S.A.. (7/18/16). "Press Release: bioMérieux – Second-Quarter 2016 Business Review". Marcy l’Étoile. 2016-07-18
Poxel S.A.. (7/18/16). "Press Release: Poxel Closes a €26.5 Million Capital Increase". Lyon. 2016-07-18
Euronext N.V.. (7/18/16). "Press Release: Biotech Pharnext Lists on Alternext to Pursue New Therapies for Alzheimer's. €30.9 Million Raised, Market Capitalization €100.4 Million". Paris. 2016-07-18
Euronext N.V.. (7/13/16). "Press Release: GenSight Biologics Lists on Euronext to Become Europe's First Listed Gene Therapy Company. €40 Million Raised, Market Capitalisation €149 Million". Paris. 2016-07-13
Valneva S.E.. (7/12/16). "Press Release: European Investment Bank Grants Valneva a €25 Million Loan to Fund R&D Activities". Lyon & Luxembourg. 2016-07-12
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top